Please enable JavaScript to continue using this application.

Compare $1521.HK vs $ALMR | Chartloom

Compare

$1521.HK vs $ALMR

1521.HK

Error

ALMR

Alamar Biosciences Inc

Compare $1521.HK vs $ALMR

1521.HK

Error

ALMRAlamar Biosciences Inc

1521.HK

Market cap

—

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

—

52W performance

—

FCF yield

—

ALMRAlamar Biosciences Inc

Market cap

$1.75B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.35x

Rev growth (TTM)

—

YTD performance

14.9%

52W performance

14.9%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

1521.HK

ALMR

Not enough overlapping price history for this window.

Detailed metrics comparison

1521.HK

ALMR

Alamar Biosciences Inc

Market Cap

1521.HK

ALMR$1.75B

Enterprise Value

1521.HK

ALMR$1.63B

Price

1521.HK

ALMR$25.27

P/E Ratio

1521.HK

ALMRN/A

P/S Ratio

1521.HK

ALMR31.58x

EV/Sales

1521.HK

ALMR29.36x

EV/EBITDA

1521.HK

ALMR0.00x

P/B Ratio

1521.HK

ALMR7.62x

P/FCF Ratio

1521.HK

ALMRN/A

EV/FCF

1521.HK

ALMR0.00x

PEG Ratio

1521.HK

ALMRN/A

Forward P/E (NTM)

1521.HK

ALMRN/A

Forward P/S (NTM)

1521.HK

ALMR12.35x

Revenue (TTM)

1521.HK

ALMR$55M

Revenue Growth (YoY)

1521.HK

ALMRN/A

Forward Rev Growth

1521.HK

ALMR39.6%

Gross Margin (TTM)

1521.HK

ALMR58.0%

Operating Margin (TTM)

1521.HK

ALMR0.0%

EBITDA Margin (TTM)

1521.HK

ALMR-45.8%

Net Margin (TTM)

1521.HK

ALMR-62.2%

FCF Margin (TTM)

1521.HK

ALMR0.0%

Net Income (TTM)

1521.HK

ALMR$-35M

FCF (TTM)

1521.HK

ALMR$0

EPS (TTM)

1521.HK

ALMR-$0.50

ROE (TTM)

1521.HK

ALMR0.0%

ROA (TTM)

1521.HK

ALMR0.0%

ROIC (TTM)

1521.HK

ALMR0.0%

Cash

1521.HK

ALMR$133M

Debt

1521.HK

ALMR$10M

Net Cash/Debt

1521.HK

ALMR$123M

Current Ratio (TTM)

1521.HK

ALMR11.85x

Quick Ratio (TTM)

1521.HK

ALMR9.67x

Debt/Equity (TTM)

1521.HK

ALMR0.03x

Debt/Assets (TTM)

1521.HK

ALMR0.0%

Interest Coverage (TTM)

1521.HK

ALMRN/A

Net Debt/EBITDA (TTM)

1521.HK

ALMR0.00x

Beta

1521.HK

ALMR-0.30

52W Performance

1521.HK

ALMR14.9%

YTD Performance

1521.HK

ALMR14.9%

% from 52W High

1521.HK

ALMR-36.2%

% from 52W Low

1521.HK

ALMR34.1%

Asset Turnover (TTM)

1521.HK

ALMR0.00x

FCF Yield (TTM)

1521.HK

ALMR0.0%

Earnings Yield (TTM)

1521.HK

ALMR-2.0%

Dividend Yield (TTM)

1521.HK

ALMRN/A

Rule of 40

1521.HK

ALMR0.0

EV/GP/RG

1521.HK

ALMR0.30

Ticker research

View 1521.HK research View ALMR research

Metric	1521.HK	ALMR Alamar Biosciences Inc
Market & Valuation
Market Cap		$1.75B
Enterprise Value		$1.63B
Price		$25.27
P/E Ratio		N/A
P/S Ratio		31.58x
EV/Sales		29.36x
EV/EBITDA		0.00x
P/B Ratio		7.62x
P/FCF Ratio		N/A
EV/FCF		0.00x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		12.35x
Revenue & Growth
Revenue (TTM)		$55M
Revenue Growth (YoY)		N/A
Forward Rev Growth		39.6%
Profitability
Gross Margin (TTM)		58.0%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		-45.8%
Net Margin (TTM)		-62.2%
FCF Margin (TTM)		0.0%
Net Income (TTM)		$-35M
FCF (TTM)		$0
EPS (TTM)		-$0.50
ROE (TTM)		0.0%
ROA (TTM)		0.0%
ROIC (TTM)		0.0%
Financial Health
Cash		$133M
Debt		$10M
Net Cash/Debt		$123M
Current Ratio (TTM)		11.85x
Quick Ratio (TTM)		9.67x
Debt/Equity (TTM)		0.03x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		-0.30
52W Performance		14.9%
YTD Performance		14.9%
% from 52W High		-36.2%
% from 52W Low		34.1%
Efficiency & Yields
Asset Turnover (TTM)		0.00x
FCF Yield (TTM)		0.0%
Earnings Yield (TTM)		-2.0%
Dividend Yield (TTM)		N/A
Other
Rule of 40		0.0
EV/GP/RG		0.30
Ticker research	View 1521.HK research	View ALMR research

Valuation

Growth & revenue

Profitability & performance

Detailed metrics comparison

1521.HK

ALMR

Alamar Biosciences Inc

Market Cap

1521.HK

ALMR$1.75B

Enterprise Value

1521.HK

ALMR$1.63B

Price

1521.HK

ALMR$25.27

P/E Ratio

1521.HK

ALMRN/A

P/S Ratio

1521.HK

ALMR31.58x

EV/Sales

1521.HK

ALMR29.36x

EV/EBITDA

1521.HK

ALMR0.00x

P/B Ratio

1521.HK

ALMR7.62x

P/FCF Ratio

1521.HK

ALMRN/A

EV/FCF

1521.HK

ALMR0.00x

PEG Ratio

1521.HK

ALMRN/A

Forward P/E (NTM)

1521.HK

ALMRN/A

Forward P/S (NTM)

1521.HK

ALMR12.35x

Revenue (TTM)

1521.HK

ALMR$55M

Revenue Growth (YoY)

1521.HK

ALMRN/A

Forward Rev Growth

1521.HK

ALMR39.6%

Gross Margin (TTM)

1521.HK

ALMR58.0%

Operating Margin (TTM)

1521.HK

ALMR0.0%

EBITDA Margin (TTM)

1521.HK

ALMR-45.8%

Net Margin (TTM)

1521.HK

ALMR-62.2%

FCF Margin (TTM)

1521.HK

ALMR0.0%

Net Income (TTM)

1521.HK

ALMR$-35M

FCF (TTM)

1521.HK

ALMR$0

EPS (TTM)

1521.HK

ALMR-$0.50

ROE (TTM)

1521.HK

ALMR0.0%

ROA (TTM)

1521.HK

ALMR0.0%

ROIC (TTM)

1521.HK

ALMR0.0%

Cash

1521.HK

ALMR$133M

Debt

1521.HK

ALMR$10M

Net Cash/Debt

1521.HK

ALMR$123M

Current Ratio (TTM)

1521.HK

ALMR11.85x

Quick Ratio (TTM)

1521.HK

ALMR9.67x

Debt/Equity (TTM)

1521.HK

ALMR0.03x

Debt/Assets (TTM)

1521.HK

ALMR0.0%

Interest Coverage (TTM)

1521.HK

ALMRN/A

Net Debt/EBITDA (TTM)

1521.HK

ALMR0.00x

Beta

1521.HK

ALMR-0.30

52W Performance

1521.HK

ALMR14.9%

YTD Performance

1521.HK

ALMR14.9%

% from 52W High

1521.HK

ALMR-36.2%

% from 52W Low

1521.HK

ALMR34.1%

Asset Turnover (TTM)

1521.HK

ALMR0.00x

FCF Yield (TTM)

1521.HK

ALMR0.0%

Earnings Yield (TTM)

1521.HK

ALMR-2.0%

Dividend Yield (TTM)

1521.HK

ALMRN/A

Rule of 40

1521.HK

ALMR0.0

EV/GP/RG

1521.HK

ALMR0.30

Ticker research

View 1521.HK research View ALMR research

Metric	1521.HK	ALMR Alamar Biosciences Inc
Market & Valuation
Market Cap		$1.75B
Enterprise Value		$1.63B
Price		$25.27
P/E Ratio		N/A
P/S Ratio		31.58x
EV/Sales		29.36x
EV/EBITDA		0.00x
P/B Ratio		7.62x
P/FCF Ratio		N/A
EV/FCF		0.00x
PEG Ratio		N/A
Forward P/E (NTM)		N/A
Forward P/S (NTM)		12.35x
Revenue & Growth
Revenue (TTM)		$55M
Revenue Growth (YoY)		N/A
Forward Rev Growth		39.6%
Profitability
Gross Margin (TTM)		58.0%
Operating Margin (TTM)		0.0%
EBITDA Margin (TTM)		-45.8%
Net Margin (TTM)		-62.2%
FCF Margin (TTM)		0.0%
Net Income (TTM)		$-35M
FCF (TTM)		$0
EPS (TTM)		-$0.50
ROE (TTM)		0.0%
ROA (TTM)		0.0%
ROIC (TTM)		0.0%
Financial Health
Cash		$133M
Debt		$10M
Net Cash/Debt		$123M
Current Ratio (TTM)		11.85x
Quick Ratio (TTM)		9.67x
Debt/Equity (TTM)		0.03x
Debt/Assets (TTM)		0.0%
Interest Coverage (TTM)		N/A
Net Debt/EBITDA (TTM)		0.00x
Performance
Beta		-0.30
52W Performance		14.9%
YTD Performance		14.9%
% from 52W High		-36.2%
% from 52W Low		34.1%
Efficiency & Yields
Asset Turnover (TTM)		0.00x
FCF Yield (TTM)		0.0%
Earnings Yield (TTM)		-2.0%
Dividend Yield (TTM)		N/A
Other
Rule of 40		0.0
EV/GP/RG		0.30
Ticker research	View 1521.HK research	View ALMR research